Navigation Links
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
Date:1/14/2014

ssays utilizing xMAP® open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com.

Statements made in this release that express Luminex Corporation's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements. Factors that could cause Luminex's actual results or performance to differ materially include risks and uncertainties relating to, among others, market demand and acceptance of Luminex's products, the Company's dependence on strategic partners for development, commercialization and distribution of products, concentration of the Company's revenue in a limited number of strategic partners, fluctuations in quarterly results due to a lengthy and unpredictable sales cycle and
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation Reports Third Quarter 2013 Results
2. LUMINEX CORPORATION TO HOST INVESTOR EVENT AT ASSOCIATION FOR MOLECULAR PATHOLOGY ANNUAL MEETING
3. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
4. Luminex Corporation Reports Second Quarter 2013 Results
5. Luminex Corporation Achieves Milestone, Ships 10,000th Instrument
6. Luminex Corporation Second Quarter Earnings Release Scheduled for July 29, 2013
7. Natural Molecular Testing Corporation Launches an Expanded Personalized Medicine Panel Built on Luminex Corporations xMAP Technology
8. Luminex Corporation and EMD Millipore Extend Their Global Supply and Distribution Agreement
9. Luminex Corporation To Present At Upcoming Investment Conferences
10. Luminex Corporation Reports First Quarter 2013 Results
11. Luminex Corporation First Quarter Earnings Release Scheduled for April 29, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Prismic Pharmaceuticals, Inc., ... FDA-regulated medical foods, today announced the election of ... to its Board of Directors. Commenting ... Peter Moriarty , Chairman and CEO of Prismic, ... and Martin Simonetti have accepted our invitation ...
(Date:7/1/2015)... YORK, Pa. , July 1, 2015  Unilife ... developer, manufacturer and supplier of injectable drug delivery systems, ... been amended as of June 30, 2015. This amendment ... least $20 million in cash receipts from customers during ... no other adjustments to any of the terms of ...
(Date:7/1/2015)... July 1, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of proprietary compounded drug ... The Nasdaq stock market closing bell on Thursday, ... success of its Go Dropless™ campaign since its ... procedures are performed annually in the U.S. and ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... and health care payer and provider organizations convened at the "Selling Pharmaceuticals in 2015" forum in ... drugs on price, features and benefits with a new model that focuses on quantifying and communicating total ... ... , ...
... platform technology designed to standardize hyperthermic perfusion treatments, today announced the appointment of Alan Hirschman , PhD to its Board of Directors. , ... , ... ... ...
Cached Medicine Technology:Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 2Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 3Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 4Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 5Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 6Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 7Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 8ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors 2ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors 3
(Date:7/1/2015)... ... July 01, 2015 , ... Sir Fazle Hasan Abed, BRAC’s founder and ... Sir Fazle has been recognised for his outstanding contribution to enhancing the world's production ... President of the World Food Prize Foundation, announced this year’s winner at a ceremony ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative leaders ... and compounding pharmacy operations, announces the most recent positioning of SuiteRx CEO, Nicholas ... event at the Venetian Las Vegas, Nevada. During this event, SuiteRx ...
(Date:7/1/2015)... ... ... The Collaborative for Children and Families (CCF) announced that it received a ... to improve quality of care and save costs for the child welfare sector by ... in New York’s Medicaid system. Experts agree that children need thorough solutions to live ...
(Date:7/1/2015)... ... July 01, 2015 , ... Did you know that infertility ... Health Month, and we at Advanced Fertility Center of Texas (AFCT) would like to ... , While infertility is often considered to be a “woman’s issue,” male fertility factors ...
(Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning social policy often has ... in FIU’s School of International and Public Affairs. , The researchers ... the National Survey on Drug Use and Health, which is a nationally representative ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2
... for workers in highly hazardous jobs is most effective at ... to 40 years of research. However, less engaging training can ... when jobs are less dangerous. More interactive types ... the threats they face on the job and avoid making ...
... ,Difficult, patient-clinician encounters have a negative impact on patients, ... study by Sheri Hinchey from the Tripler Army Medical ... VA Medical Centre in Milwaukee. Their findings 1 ... as difficult by their physicians and are less likely ...
... at Sahlgrenska University Hospital in Gothenburg and at Alingss ... 18 and 65. Half the group was randomly allocated ... to maintain their usual lifestyle. Both groups received ... increased their physical activity on their own, but with ...
... Women who have experienced hot flushes and other symptoms ... developing the most common forms of breast cancer than postmenopausal ... recent study by researchers at Fred Hutchinson Cancer Research Center. ... relationship between menopausal symptoms and breast cancer risk are available ...
... by researchers at Washington University School of Medicine in ... approach to treating cancer. The strategy takes aim ... forming new blood vessels that feed tumor growth. When ... animals developed vascular tumors, primarily in the liver, which ...
... AURORA, Colo. (Jan. 25, 2011) A new study ... Program at The Children,s Hospital and Colorado Health Outcomes ... Medicine explores the barriers, facilitators and alternative approaches to ... statewide immunization registry. Reminder or recall messages, usually in ...
Cached Medicine News:Health News:Highly interactive training helps workers in dangerous jobs avoid deadly mistakes 2Health News:'Difficult' patients more likely to experience worse symptoms 2Health News:Hot flushes are linked with a significant reduction in breast cancer risk 2Health News:Study raises safety concerns about experimental cancer approach 2Health News:Study raises safety concerns about experimental cancer approach 3Health News:New study finds reminders for immunizations challenging for pediatric practices 2Health News:New study finds reminders for immunizations challenging for pediatric practices 3
... complete imaging access, with nearly 100 percent ... imaging C-Arms can pan from head to ... patient. Anesthesiologists will appreciate this table for ... construction, and ease of operation. The key ...
...
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: